LT2845598T - Preparatas, skirtas naudoti netipinės osteoporozės prevencijai ir gydymui - Google Patents

Preparatas, skirtas naudoti netipinės osteoporozės prevencijai ir gydymui

Info

Publication number
LT2845598T
LT2845598T LTEP12874454.7T LT12874454T LT2845598T LT 2845598 T LT2845598 T LT 2845598T LT 12874454 T LT12874454 T LT 12874454T LT 2845598 T LT2845598 T LT 2845598T
Authority
LT
Lithuania
Prior art keywords
prophylaxis
preparation
treatment
atypical
osteoporosis
Prior art date
Application number
LTEP12874454.7T
Other languages
English (en)
Inventor
Villorij Ivanovich STRUKOV
Olga JHONES
Evgenij Nikolaevich KRUTIAKOV
Konstantin Gennad`evich ELISTRATOV
Original Assignee
Obshestvo S Ogranichennoj Otvetstvennostju "Parafarm"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Obshestvo S Ogranichennoj Otvetstvennostju "Parafarm" filed Critical Obshestvo S Ogranichennoj Otvetstvennostju "Parafarm"
Publication of LT2845598T publication Critical patent/LT2845598T/lt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5929,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/5939,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Insects & Arthropods (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Animal Husbandry (AREA)
  • Zoology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Fodder In General (AREA)
LTEP12874454.7T 2012-04-19 2012-08-21 Preparatas, skirtas naudoti netipinės osteoporozės prevencijai ir gydymui LT2845598T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2012115654/15A RU2497533C1 (ru) 2012-04-19 2012-04-19 Способ и препарат для профилактики и лечения атипичного остеопороза с нормальной или повышенной минерализацией костной ткани с наличием полостных образований в трабекулярных отделах костей (и ему близких состояниях при избыточной массе и метаболическом синдроме)
PCT/RU2012/000687 WO2013157982A1 (ru) 2012-04-19 2012-08-21 Препарат и способ профилактики и лечения атипичного остеопороза

Publications (1)

Publication Number Publication Date
LT2845598T true LT2845598T (lt) 2017-02-27

Family

ID=49383800

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP12874454.7T LT2845598T (lt) 2012-04-19 2012-08-21 Preparatas, skirtas naudoti netipinės osteoporozės prevencijai ir gydymui

Country Status (17)

Country Link
US (1) US9827273B2 (lt)
EP (1) EP2845598B1 (lt)
JP (1) JP6286417B2 (lt)
CN (1) CN104736161B (lt)
AU (1) AU2012377476B2 (lt)
BR (1) BR112014025990B1 (lt)
CA (1) CA2870823C (lt)
DK (1) DK2845598T3 (lt)
EA (1) EA026533B1 (lt)
ES (1) ES2616035T3 (lt)
IL (1) IL235169B (lt)
IN (1) IN2014DN09780A (lt)
LT (1) LT2845598T (lt)
PL (1) PL2845598T3 (lt)
RU (1) RU2497533C1 (lt)
UA (1) UA111536C2 (lt)
WO (1) WO2013157982A1 (lt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20180249751A1 (en) * 2009-11-30 2018-09-06 Parapharm Llc Preparation for Treating Androgen Deficiency in Women
RU2498811C1 (ru) * 2012-04-19 2013-11-20 Общество С Ограниченной Ответственностью "Парафарм" Способ профилактики и лечения остеопороза и переломов костей и препарат для профилактики и лечения остеопороза и переломов костей
US20190381072A1 (en) * 2012-04-19 2019-12-19 Parapharm Llc Preparation for the Prophylaxis and Treatment of Atypical Osteoporosis
RU2564111C9 (ru) * 2013-07-03 2016-03-20 Общество С Ограниченной Ответственностью "Парафарм" Применение адсорбированного гомогената трутневого расплода и витаминов группы d и/или их активных метаболитов для профилактики и лечения острых респираторных заболеваний и гриппа
RU2577225C1 (ru) * 2015-03-27 2016-03-10 Общество С Ограниченной Ответственностью "Парафарм" Препарат и способ для лечения дефицита андрогенов у женщин, содержащий энтомологические протеины

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1101684C (zh) * 1997-07-24 2003-02-19 薛大权 蜂蛹钙制剂
BRPI0411020A (pt) * 2003-06-06 2006-07-18 Wyeth Corp perfil de expressão de gene, métodos de identificar agentes modulares do caminho de wnt, de preparar um perfil de expressão de gene, de triar um agente que realce a remodelagem associada com a carga óssea e reagentes que se ligam às proteìnas que modulam a remodelagem óssea e/ou mineralização óssea, de tratar uma doença ou distúrbio de mineralização óssea, de modular a mineralização óssea em uma célula e a mineralização óssea e/ou remodelagem óssea em um paciente e de determinar se um composto ou uma composição realçam o efeito de carga óssea na atividade/função e/ou mineralização da célula óssea, agente candidato para tratar uma condição de massa óssea baixa e composição
MX2010008906A (es) * 2008-02-13 2010-11-05 Dsm Ip Assets Bv Uso combinado de 25-hidroxi-vitamina d3 y vitamina d3 para mejorar la densidad mineral osea y para tratar osteoporosis.
RU2412616C1 (ru) * 2009-11-30 2011-02-27 Общество С Ограниченной Ответственностью "Парафарм" Биологически активная добавка к пище для профилактики заболеваний остеопорозом

Also Published As

Publication number Publication date
EA201401155A1 (ru) 2015-05-29
US20150224150A1 (en) 2015-08-13
CA2870823A1 (en) 2013-10-24
BR112014025990B1 (pt) 2021-02-17
JP6286417B2 (ja) 2018-02-28
BR112014025990A2 (pt) 2017-06-27
US9827273B2 (en) 2017-11-28
CN104736161B (zh) 2021-07-06
RU2497533C1 (ru) 2013-11-10
IN2014DN09780A (lt) 2015-07-31
IL235169B (en) 2019-10-31
WO2013157982A1 (ru) 2013-10-24
CN104736161A (zh) 2015-06-24
IL235169A0 (en) 2014-12-31
DK2845598T3 (en) 2017-04-10
EP2845598A4 (en) 2015-10-28
ES2616035T3 (es) 2017-06-09
JP2015516974A (ja) 2015-06-18
PL2845598T3 (pl) 2017-07-31
EP2845598A1 (en) 2015-03-11
UA111536C2 (uk) 2016-05-10
EA026533B1 (ru) 2017-04-28
EP2845598B1 (en) 2017-01-04
AU2012377476A1 (en) 2014-12-11
AU2012377476A8 (en) 2014-12-18
CA2870823C (en) 2017-10-03
AU2012377476B2 (en) 2017-10-05

Similar Documents

Publication Publication Date Title
IL266582A (en) Compositions and methods for the treatment of hemoglobinopathies
HK1220129A1 (zh) 益生菌菌株用於治療或預防骨質疏鬆
ZA201408056B (en) Compositions and methods for the treatment of mucositis
HK1207304A1 (en) Crhr1 antagonists for use in the treatment of patients having crh overactivity crh crhr1
IL236655A0 (en) Microporous zirconium silicate for the treatment of hyperkalemia in hypercalcemic patients and improved preparations containing calcium for the treatment of hyperkalemia
HK1203149A1 (en) Novel dosage form and formulation of abediterol
HK1211221A1 (en) Formulations for the treatment and prevention of obesity
IL236823A0 (en) Preparations for use in the treatment of bone defects
ZA201408055B (en) Compositions and methods for the treatment of local pain
PL2845598T3 (pl) Preparat do stosowania w profilaktyce i leczeniu nietypowej osteoporozy
ZA201307058B (en) Use of polyaminoisoprenyl derrivatives in antobiotic or antisertic treatment
PT2872176T (pt) Carboranilporpirinas para utilização no tratamento de cancro
IL235272B (en) Alfentanil composition for the treatment of acute pain
PL2839827T3 (pl) Kompozycja do higieny skóry i/lub nawadniania
HUE037921T2 (hu) Készítmény hipokalcémia kezelésére kérõdzõkben
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
LT2863932T (lt) Kompozicija, skirta naudoti limfedemos gydymui
GB201223371D0 (en) Novel mucinase for use in therapy or prophylaxis
GB201207102D0 (en) CRHR1 antagonists for use in the treatment of patients having CRH overactivity
EP2841164A4 (en) COMPOSITIONS AND USE PROCEDURES FOR THE SKIN
GB201208770D0 (en) Compounds for use in the treatment of adenovirus infections